The Kadayat Research Group focuses on interdisciplinary research at the interface of 1. computational drug discovery, 2. medicinal chemistry, and 3. STEM education and health equity. Our mission is to advance science and education through innovative research that addresses both therapeutic challenges and educational and health disparities.

1. Computational Drug Design & Discovery: We utilize state-of-the-art computational tools—including molecular modeling, virtual screening, docking, and QSAR studies—to accelerate the identification and optimization of drug candidates. Our work aims to predict drug-target interactions, assess ADMET properties, and support drug repurposing efforts.

2. Synthesis of Small Molecule Drugs & Biochemical Assay Development: We design and synthesize novel small molecules targeting cancer, metabolic disorders, and neglected diseases. Using advanced techniques in organic synthesis, purification (flash chromatography, HPLC), and characterization (NMR, LC-MS), we develop and evaluate new chemical entities. These compounds are tested through custom-designed biochemical assays to assess their therapeutic potential.

3. STEM Educational Practices & Health Disparities: Our group also conducts research in STEM education with a focus on evidence-based teaching methods, active learning, and curriculum development using educational technologies (e.g., ExamSoft, Canvas). In parallel, we investigate health disparities in pharmacy practice—examining chronic disease management, health literacy, drug addiction, and access to care through models like tele-pharmacy. We aim to develop data-driven strategies that promote inclusive education and equitable healthcare outcomes.